Galia Inbar - 28 Feb 2022 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
EVP, Chief Human Resources Officer and Global Communications and Brand
Signature
/s/ Dov Bergwerk as attorney-in-fact for Galia Inbar
Issuer symbol
TEVA
Transactions as of
28 Feb 2022
Transactions value $
$0
Form type
4
Filing time
02 Mar 2022, 06:48:22 UTC
Previous filing
19 Aug 2021
Next filing
08 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +4.83K +100% 9.66K 28 Feb 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -4.83K -33.33% $0.00 9.66K 28 Feb 2022 Ordinary Shares 4.83K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on February 28, 2020, with 4,828 having vested on each of February 28, 2021 and February 28, 2022, 4,828 vesting on February 28, 2023 and 4,829 vesting on February 28, 2024.

Remarks:

EVP, Chief Human Resources Officer and Global Communications and Brand